rotenone has been researched along with Laryngeal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, JJ; Estes, JR; Kokumai, M; Konoshima, T; Kozuka, M; Li, L; McPhail, AT; McPhail, DR; Terada, H; Wang, HK | 1 |
| Hematulin, A; Ingkaninan, K; Meethang, S; Sagan, D | 1 |
2 other study(ies) available for rotenone and Laryngeal Neoplasms
| Article | Year |
|---|---|
Antitumor agents, 138. Rotenoids and isoflavones as cytotoxic constitutents from Amorpha fruticosa.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Drug Screening Assays, Antitumor; Humans; Isoflavones; Laryngeal Neoplasms; Plants, Medicinal; Rotenone; Tumor Cells, Cultured | 1993 |
Derris scandens Benth extract potentiates radioresistance of Hep-2 laryngeal cancer cells.
Topics: Cell Line, Tumor; Cell Movement; Cell Survival; Derris; G2 Phase Cell Cycle Checkpoints; Humans; Laryngeal Neoplasms; Phosphorylation; Plant Extracts; Proto-Oncogene Proteins c-akt; Radiation Tolerance | 2012 |